The Gene Therapy Initiative (GTI) at UC San Diego, California Life Sciences (CLS) and California Institute for Regenerative Medicine (CIRM) converge in La Jolla, CA – September 16 & 17 to discuss the Future of Cell & Gene Therapy. 

• Day 1 on Sept. 16, hosted by UC San Diego GTI, features academic and industry leaders showcasing cutting‑edge cell‑based safety models, ex‑vivo and in‑vivo genetic therapy technologies, and bold bench‑to‑bedside strategies.
• Day  2 on Sept. 17, hosted by CLS and CIRM, features panels on scientific innovation, manufacturing, patient delivery, and commercialization. 

Each day stands on its own, so participants can choose to attend one or attend both. The program is built for everyone working in this space across Southern California, across therapeutics, manufacturing, research, capital, and the legal and policy infrastructure that supports the field.

Attend both days and receive a discount! Seats are limited. Register today at the event websites provided.

• Present Your Research on Sept. 16: We are heavily promoting our poster sessions! This is your chance to get your work in front of the biggest names in the field. Submit an Abstract by Aug 7th.